The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Browse by Topic

  1. Acute Respiratory Infections (200)
  2. Airways (485)
  3. Anaesthesia (323)
  4. Back (303)
  5. Bone, Joint and Muscle Trauma (279)
  6. Breast Cancer (91)
  7. Childhood Cancer (51)
  8. Colorectal Cancer (276)
  9. Consumers and Communication (103)
  10. Cystic Fibrosis and Genetic Disorders (172)
  11. Dementia and Cognitive Improvement (279)
  12. Depression, Anxiety and Neurosis (787)
  13. Developmental, Psychosocial and Learning Problems (188)
  14. Drugs and Alcohol (100)
  15. Ear, Nose and Throat Disorders (150)
  16. Editorial Unit (12756)
  17. Effective Practice and Organisation of Care (154)
  18. Epilepsy (99)
  19. Eyes and Vision (204)
  20. Fertility Regulation (105)
  21. Gynaecological Cancer (189)
  22. Haematological Malignancies (140)
  23. Heart (212)
  24. Hepato-Biliary (401)
    1. ACUTE ACALCULOUS CHOLECYSTITIS (K81.0) (5)
    2. ACUTE BLEEDING GASTRIC VARICES (I86.4) (6)
    3. ACUTE BLEEDING OESOPHAGEAL VARICES (I85.0) (18)
    4. ACUTE CALCULOUS CHOLECYSTITIS (K80.0) (9)
    5. ACUTE FATTY LIVER OF PREGNANCY (026.6) (0)
    6. ACUTE FULMINANT HEPATITIS B (HEPATITIS B ACUTA CUM COMA HEPATICUM (B16.9) (3)
    7. ACUTE FULMINANT HEPATITIS C (B17.1) (2)
    8. ACUTE HEPATIC FAILURE (K72.0) (7)
    9. ACUTE HEPATITIS A (HEPATITIS A ACUTA (B15.9) (2)
    10. ACUTE HEPATITIS B (HEPATITIS B ACUTA B16.9) (12)
    11. ACUTE HEPATITIS C (B17.1) (5)
    12. ACUTE-ON-CHRONIC LIVER FAILURE (K72.1) (4)
    13. ACUTE SICKLE HEPATITIS CRISES (K72.0) (0)
    14. ADENOVIRUS HEPATITIS (B19.9) (0)
    15. ALCOHOLIC CIRRHOSIS (K70.3) (9)
    16. ALCOHOLIC FATTY LIVER (K70.0) (5)
    17. ALCOHOLIC HEPATITIS (K70.1) (8)
    18. ALPHA1-ANTITRYPSYN DEFICIENCY (E88.0) (0)
    19. AMOEBIC LIVER ABSCESS (A06.4) (2)
    20. AMYLOIDOSIS COMPLICATING MYELOMA (C90.0) (0)
    21. ANEURYSMA OF THE HEPATIC ARTERY (I72.8) (0)
    22. ASCARIASIS (B77.9) (0)
    23. ASCITES (R18) (6)
    24. ATRESIA OF THE COMMON BILE DUCT (Q44.2) (1)
    25. AUTOIMMUNE HEPATITIS (K75.4) (1)
    26. BENIGN BILIARY CYSTADENOMA (D13.5) (M8161/0) (0)
    27. BENIGN BILIARY HEMANGIOMA (D18.0) (M9120.0) (0)
    28. BENIGN BILIARY PAPILLOMATOSIS (D13.5) (M8060/0) (0)
    29. BENIGN HEPATIC ADENOMA (D13.4) (M8170/0) (5)
    30. BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS (BRIC) (K83.1) (0)
    31. BENIGN STRICTURES OF THE BILE DUCT SYSTEM (K83.1) (0)
    32. BENIGN TUMOURS OF THE COMMON BILE DUCT (D13.5) (M8000/0) (0)
    33. BENIGN TUMOURS OF THE GALLBLADDER (D13.5) (M8000/0) (0)
    34. BILIARY FISTULA (K83.3) (0)
    35. BLEEDING OESOPHAGEAL VARICES (I85.0) (6)
    36. BUDD-CHIARI SYNDROME (I82.0) (0)
    37. CARRIERS OF HEPATITIS VIRUS (Z22.5) (7)
    38. CHOLESTASIS (K83.1) (0)
    39. CHOLESTASIS OF PREGNANCY (O26.6) (0)
    40. CHOLODOCHOLITHIASIS (K80.5) (14)
    41. CHRONIC VIRAL HEPATITIS B WITH DELTA AGENTS (B18.0) (5)
    42. CHRONIC VIRAL HEPATITIS B WITHOUT DELTA AGENTS (B18.1) (42)
    43. CHRONIC VIRAL HEPATITIS C (B18.2) (20)
    44. CONDITIONS ASSOCIATED WITH LIVER TRANSPLANTATION (Z94.4) (6)
    45. CONGENITAL CYSTIC MALFORMATIONS OF THE BILIARY TREE (Q44.5) (0)
    46. COXSACKIE B VIRUS HEPATITIS (B33.8) (K77.0*) (0)
    47. CRIGLER-NAJJAR'S SYNDROME (E 80.5) (0)
    48. CRYPTOGENIC CIRRHOSIS (K74.6) (0)
    49. CYTOMEGALOVIRUS HEPATITIS (B25.1) (K77.0*) (0)
    50. EBOLA VIRUS (A98.4) (0)
    51. EPSTEIN-BARR VIRUS HEPATITIS (B17.8) (0)
    52. ERYTHROPOIETIC PROTOPORPHYRIA (E 80.0) (0)
    53. FAMILIAL MEDITERRANEAN FEVER (E85.0) (0)
    54. FATTY LIVER IN INFANCY AND CHILDHOOD (K76.0) (0)
    55. FATTY LIVER IN OBESITY (K76.0) (12)
    56. FIBROLAMELLAR MALIGNANT HEPATIC TUMOURS (C22.7) (M8171/3) (2)
    57. FIRST BLEEDING FROM GASTRIC VARICES (I86.4) (1)
    58. FIRST BLEEDING FROM OESOPHAGEAL VARICES (I85.0) (0)
    59. FULMINANT HEPATITIS A (HEPATITIS A ACUTA CUM COMA HEPATICUM (B15.0) (2)
    60. GALACTOSAEMIA (E74.2) (0)
    61. GALLBLADDER CANCER (C23) (M8000/3) (1)
    62. GALLBLADDER DYSKINESIA (K82.8) (1)
    63. GALLSTONE PANCREATITIS (K80.2) (K85) (0)
    64. GALLSTONES IN THE COMMON BILE DUCT INCLUDING CHOLANGITIS (K80.3) (11)
    65. GALLSTONES IN THE GALLBLADDER (K80.2) (13)
    66. GAUCHER'S DISEASE (E75.2) (0)
    67. GLYCOGEN STORAGE DISEASE (E 74.0) (0)
    68. HAEMOCHROMATOSIS (E83.1) (3)
    69. HEPATIC AMEBIASIS (A06.4) (0)
    70. HEPATIC AMYLOIDOSIS (E85.4)(K77.8*) (0)
    71. HEPATIC ARTERIO-VENOUS SHUNTS (Q26.6) (0)
    72. HEPATIC ENCEPHALOPATHY (K72.9) (9)
    73. HEPATIC PORPHYRIAS (E80.2) (0)
    74. HEPATIC SARCOIDOSIS (D86.8) (0)
    75. HEPATITIS E (B17.2) (0)
    76. HEPATITIS F (B17.8) (0)
    77. HEPATITIS G (B17.8) (0)
    78. HEPATOBLASTOMA (C22.2) (M8970/3) (1)
    79. HEPATOCELLULAR CARCINOMA (C22.0) (M8170/3) (19)
    80. HEPATO-RENAL SYNDROME (K76.7) (2)
    81. HEREDITARY FRUCTOSE INTOLERANCE (E74.1) (0)
    82. HEREDITARY HAEMORRHAGIC TELEANGIECTASIA (I78.0) (0)
    83. HEREDITARY TYROSINEMIA (E70.2) (0)
    84. HERPES SIMPLEX VIRUS HEPATITIS (B00.8) (K77.0*) (0)
    85. HOMOCYSTINURIA (E72,1) (0)
    86. HYDATID DISEASE (B67.8) (K77.0*) (1)
    87. HYPERPHENYLALANINEMIA (E70.1) (0)
    88. INFANT CHILDHOOD CIRRHOSIS (P78.8) (0)
    89. INTRA-HEPATIC ANEURYSMS (I72.8) (0)
    90. LAPAROSCOPIC SURGERY (24)
    91. LEPTOSPIROSIS (A27.9) (6)
    92. LIVER FLUKES (B66.3) (0)
    93. LIVER TRANSPLANTATION AND RELATED SURGERY (KJJC) (ACCORDING TO NCSP) (34)
      1. Antibody induction versus corticosteroid induction for liver transplant recipientsReview
      2. Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipientsReview
      3. Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virusReview
      4. Cardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver resectionReview
      5. Celsior solution versus University of Wisconsin solution in liver preservation for transplantationProtocol
      6. Chinese herbal medicines for adverse events of transarterial chemoembolization in patients with primary liver cancerProtocol
      7. Conversion of calcineurin inhibitor treatment to target of rapamycin inhibitor treatment versus continuation of calcineurin inhibitor treatment for liver transplant recipientsProtocol
      8. Cryotherapy for liver metastasesReview
      9. Fibrin-based haemostatic agents for reducing blood loss in adult liver resectionProtocol
      10. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patientsMajor ChangeProtocol
      11. Ischaemic pre-conditioning for elective liver resections performed under vascular occlusionReview
      12. Ischaemic preconditioning for liver transplantationReview
      13. Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastasesReview
      14. Methods of decreasing infection to improve outcomes after liver resectionsReview
      15. Methods of preventing bacterial sepsis and wound complications after liver transplantationReview
      16. Methods of vascular occlusion for elective liver resectionsReview
      17. Methods to decrease blood loss and transfusion requirements for liver transplantationReview
      18. Methods to decrease blood loss during liver resection: a network meta-analysisReview
      19. Mycophenolate mofetil for liver-transplanted patientsProtocol
      20. Nutritional interventions for liver-transplanted patientsReview
      21. Nutritional support for liver diseaseReview
      22. Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumoursReview
      23. Perfusion techniques for liver retrieval in liver donorsProtocol
      24. Pharmacological interventions for ischaemia reperfusion injury in liver resection surgery performed under vascular controlReview
      25. Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver resectionReview
      26. Pharmacological interventions to decrease ischaemia reperfusion injury in liver transplantationProtocol
      27. Pharmacological interventions versus no pharmacological intervention for ischaemia reperfusion injury in liver resection surgery performed under vascular controlReview
      28. Piggy-back graft for liver transplantationReview
      29. Preoperative physical exercise training for patients scheduled for major abdominal surgeryProtocol
      30. Routine drainage for orthotopic liver transplantationReview
      31. Techniques for liver parenchymal transection in liver resectionReview
      32. Techniques of flushing and reperfusion for liver transplantationReview
      33. Transarterial (chemo)embolisation versus other nonsurgical ablation methods for liver metastasesProtocol
      34. Veno-venous bypass versus none for liver transplantationReview
    94. MALIGNANT ANGIOSARCOMA (C22.3) (M9120/3) (0)
    95. MALIGNANT BILIARY CYSTADENOCARCINOMA (C24.9) (M8440/3) (1)
    96. MALIGNANT CHOLANGIOCARCINOMA INCLUDING PERIAMPULLAR CANCER (C24.1) (M8160/3) (2)
    97. MALIGNANT COMBINED HEPATO-CELLULAR CHOLANGIOCARCINOMA (C22.0) (M8180/3) (4)
    98. MARBURG VIRUS DISEASE (A98.3) (0)
    99. MEASLE HEPATITIS (B17.8) (B05.8) (0)
    100. MUCOPOLYSACCHARIDOSIS (E76.3) (0)
    101. NIEMANN-PICK DISEASE (E 75.2) (0)
    102. PERIHEPATITIS (K65.8) (0)
    103. PHENYLKETONURIA (E 70.1) (0)
    104. PRIMARY AMYLOIDOSIS (E85.9) (0)
    105. PRIMARY BILIARY CIRRHOSIS (K74.3) (12)
    106. PRIMARY SCLEROSING CHOLANGITIS (K83.0) (4)
    107. PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (BYLER´S DISEASE) (K83.1) (0)
    108. Q FEVER (A78) (0)
    109. RECURRENT BLEEDING FROM GASTRIC VARICES (I86.4) (1)
    110. RECURRENT BLEEDING FROM OESOPHAGEAL VARICES (I85.0) (8)
    111. RUBELLA HEPATITIS (B17.8) (B06.8) (0)
    112. SECONDARY AMYLOIDOSIS (E85.3) (0)
    113. SECONDARY HEPATIC TUMOURS (C78.7) (M8000/6) (8)
    114. SICKLE CELL CHOLELITHIASIS (K80.8) (0)
    115. SICKLE CELL INTRAHEPATIC CHOLESTASIS (K83.1) (0)
    116. SPHINCTER OF ODDI DYSFUNCTION (K82.8) (1)
    117. SPONTANEOUS BACTERIAL PERITONITIS (K65.0) (2)
    118. TOXIC LIVER DISEASE DUE TO PARACETAMOL (ACETAMINOPHEN) (K71.9) (Y45.5) (5)
    119. TOXOCARA CANIS (B83.0) (0)
    120. TRICHINIASIS (B75) (0)
    121. TYPE IV GLYCOGENOSIS (E74.0) (0)
    122. TYROSINAEMIA (E70.2) (0)
    123. VARICELLA VIRUS HEPATITIS (B17.8) (0)
    124. VENO-OCCLUSIVE DISEASE (K76.5) (0)
    125. VON GIERKE'S DISEASE (E74.0) (0)
    126. WILSON'S DISEASE (E83.0) (1)
  25. HIV/AIDS (160)
  26. Hypertension (130)
  27. Incontinence (163)
  28. Infectious Diseases (162)
  29. Inflammatory Bowel Disease and Functional Bowel Disorders (125)
  30. Injuries (233)
  31. Lung Cancer (41)
  32. Menstrual Disorders and Subfertility (261)
  33. Metabolic and Endocrine Disorders (147)
  34. Methodology Review (37)
  35. Movement Disorders (93)
  36. Multiple Sclerosis and Rare Diseases of the Central Nervous System (60)
  37. Musculoskeletal (351)
  38. Neonatal (395)
  39. Neuromuscular Disease (269)
  40. Occupational Safety and Health (131)
  41. Oral Health (223)
  42. Pain, Palliative and Supportive Care (316)
  43. Peripheral Vascular Diseases (435)
  44. Pregnancy and Childbirth (683)
  45. Prostatic Diseases and Urologic Cancers (58)
  46. Public Health (40)
  47. Renal (248)
  48. Schizophrenia (270)
  49. Sexually Transmitted Infections (12)
  50. Sexually Transmitted Infections (19)
  51. Skin (298)
  52. Stroke (227)
  53. Tobacco Addiction (92)
  54. Upper Gastrointestinal and Pancreatic Diseases (212)
  55. Wounds (212)

SEARCH